Castlekeep Investment Advisors »

Supernus Pharmaceuticals shares owned by Castlekeep Investment Advisors

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Castlekeep Investment Advisors from 13F filings

Historical chart of Castlekeep Investment Advisors investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Castlekeep Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Castlekeep Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.4M 50k 47.79
2025-06-30 $1.3M 40k 31.52

More positions owned by Castlekeep Investment Advisors

Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Spdr Series Trust S&p Bk Etf (KBE)
Spdr Series Trust Bloomberg 3-12 M (BILS)
Vanguard Specialized Funds Div App Etf (VIG)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Tortoise Capital Series Trus North Amern Pipe (TPYP)
Ishares Tr Sp Smcp600vl Etf (IJS)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Great Lakes Dredge & Dock Corporation (GLDD)
Golub Capital BDC (GBDC)
Midcap Financial Invstmnt Com New (MFIC)
Boeing Company (BA)
Oaktree Specialty Lending Corp (OCSL)
Citigroup Com New (C)

View all positions for Castlekeep Investment Advisors

Top funds holding Supernus Pharmaceuticals

BlackRock
Vanguard Group
Dimensional Fund Advisors
Armistice Capital
Macquarie Group
State Street Corporation
Point72 Asset Management
Renaissance Technologies
Citadel Advisors
Geode Capital Management
Stephens Investment Management Group
Loomis, Sayles and
Woodline Partners
Goldman Sachs Group
Jennifer Ranahan

View all funds holding Supernus Pharmaceuticals